Wei Zhang, Ph.D.Principal Scientist, Analytical Development at Biogen
Dr. Zhang is currently working in the Bioassay Group of the Analytical Development Department of Biogen and is responsible for development and qualification of binding and cell-based potency assays as well as impurity assays for process development, product release and stability testing of Biogen’s therapeutic protein and gene therapy products. His group also manages inventory and production of critical reagents for bioassays. Before he joined Biogen, he had worked at Genzyme and Phylos on assay development for various projects, including gene and cell therapies and protein binder screening. He received his B.S. from Peking University and Ph.D. from Cornell University. He did his post-doctoral work at the Brigham and Women’s Hospital of Harvard Medical School.